Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAVAFENIX versus atorvastatin in high coronary heart disease-risk mixed dyslipidaemia
2012-000575-17Phase 3Completed
- Sponsor
- SMB Laboratoires
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in combined dyslipidaemia and lipid disorder comparing PRAVAFENIX fixed-dose combination with Atorvastatin 20 mg (2 arms). Started Oct 2012; status: completed.
02
Drugs
pravastatin + fenofibrateatorvastatin
03
Conditions
combined dyslipidaemialipid disorder
Beyond the preview
Go deeper on 2012-000575-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000575-17.